Global X S&P Biotech ETF (ASX:CURE)

Assets	51.67M
Expense Ratio	0.45%
PE Ratio	n/a
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a
1-Year Return	+64.34%

Volume	2,269
Open	77.37
Previous Close	77.37
Day's Range	76.89 - 77.57
52-Week Low	46.01
52-Week High	81.49
Beta	0.33
Holdings	10
Inception Date	Nov 8, 2018

About CURE

The Global X S&P Biotech ETF, identified by its ticker CURE, endeavors to replicate the overall financial performance, encompassing both capital gains and dividends, of the S&P Biotechnology Select Industry Index, before any management fees and operational costs are deducted.

• Asset Class: Equity
• Category: Health Care
• Region: North America
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: CURE
• Provider: Global X
• Index Tracked: S&P Biotechnology Select Industry

Performance

CURE had a total return of 64.34% in the past year, including dividends. Since the fund's inception, the average annual return has been 9.20%.

Top Holdings

14.51% of assets

Name	Symbol	Weight
Twist Bioscience Corporation	TWST	1.73%
Oruka Therapeutics, Inc.	ORKA	1.57%
Apogee Therapeutics, Inc.	APGE	1.53%
Praxis Precision Medicines, Inc.	PRAX	1.51%
Dianthus Therapeutics, Inc.	DNTH	1.38%
Natera, Inc.	NTRA	1.37%
Kymera Therapeutics, Inc.	KYMR	1.37%
Halozyme Therapeutics, Inc.	HALO	1.35%
Insmed Incorporated	INSM	1.35%
Protagonist Therapeutics, Inc.	PTGX	1.35%

Data Sources: S&P Global Market Intelligence, Financial Modeling Prep, and more

Historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep. Several fund data points are also provided by Finnhub.

Last checked:

Sep 1, 2026

Data Sources Report a data error